About Rhapsody Biologics

About company

Rhapsody Biologics was launched in October 2009 and has created a versatile Personalized Peptide Vaccine (PPV) platform to predict and optimize peptide vaccines for use at an individual and population level.The PPV platform will bring the vaccine development industry into the age of personalized medicine. As the field of peptide vaccines grows, the need for a predictive method to create optimal peptide(s) will alsoincrease. Rhapsody Biologics will facilitate the creation of a series of more efficacious vaccines in diverse indications encompassing cancer therapy and infectious diseases.